FITB · sample dossier
48/100
Stale StatementsGenerated Oct 17, 2026 · 10:00 AM UTC · 2 hours ago
This copy is frozen (Oct 17). Sign in to run the same work — filings, valuation, bull and bear, sources — on any US stock or ETF, in about 90 seconds.
Run a fresh dossierFifth Third BancorpXNYS
HOLD
70% convictionScore 48 · Hold
A mixed picture — no strong reason to buy or sell right now.
The stock trades 33.5% above our estimate.
Current price
$50.37
Estimated value range
$33.34 – $34.05
Gap vs AlphaDog estimate
-33.5%
Narrow evidence — range rests on a single usable method.
The price is above our estimate, providing little valuation support.
Price
Price when available
Pick how far back the chart looks
1 month
-5.4%
3 months
-12.2%
6 months
+0.1%
1 year
+17.4%
Fifth Third Bancorp is a bank holding company capitalized at $45.68B, trading at a P/E of 16.96 and a Price/Book of 1.41.
No material changes found in the last 30 days.
Score 48 · Hold
Jun 30, 2026
A newer quarter has been reported and is not in these statements. The rating is capped at Hold until the statements catch up.
Value-sensitive setup
| Factor | Score |
|---|---|
| Quality | 38 out of 100 (Weak). Business health — profits, returns, and consistency. Higher means a more durable company. |
| Growth | 54 out of 100 (Neutral). How fast sales and earnings are rising. Higher means the business is expanding faster. |
| Value | 76 out of 100 (Strong). How cheap the stock looks for what you get. Higher means a more attractive price. |
| Safety | 40 out of 100 (Neutral). Balance-sheet cushion and fewer red flags. Higher means less risk of a nasty surprise. |
| Momentum | 31 out of 100 (Weak). Recent share-price trend. Higher means buyers have been in control lately. |
A calmer look at both sides of the Fifth Third Bancorp story
The consensus Hold stance and debate draw fail to confront that Fifth Third Bancorp trades at an unjustifiable 17.0 P/E valuation premium against peers CFG at 13.8 and MTB at 11.4 while generating a sub-par 0.9% ROA.
The lauded 44.4% YoY revenue growth is an operational mirage, as severe +35.9% YoY share count dilution drove an EPS contraction of -5.7% YoY. Consensus treats the 23.2% net profit margin as a proxy for franchise safety while ignoring the lack of operating leverage on an expanded equity base. Furthermore, technical structure is broken with the stock down 12.2% over three months and trading below both its MA50 and MA200. Anchoring valuation to Q2 2026 results that are 92 days old and stale leaves investors exposed to multiple compression as diluted earnings underperform.
Absence of Debt/Equity and EV/EBITDA ratios in the analysis, obscuring balance-sheet leverage and capital adequacy on a $45.68B market capitalization.
Failure to investigate the root cause of the aggressive +35.9% YoY increase in common shares outstanding, which entirely erased the benefit of 44.4% top-line growth and drove EPS down 5.7% YoY.
Reliance on 92-day-old financial disclosures from 2026-07-17 to assess profitability, completely missing post-July net interest margin and credit migration trends.
Awarding a premium 17.0 P/E and 1.4 P/B multiple to a regional lender generating an ROA of only 0.9%, well below peer profitability thresholds.
Touting $1.09M in insider buying as a bullish catalyst when it accounts for an immaterial 0.002% of the company's $45.68B market capitalization.
Highlighting $3.16 FCF per share as proof of capital strength while per-share earnings contracted 5.7% YoY under massive dilution.
Revenue Growth YoY drops below 44.4%
Net Margin falls below 23.2%
Cash after investing
Cash-flow details are thin for FITB — check the Financials tab when you can.
Objective checkpoints to watch before the next earnings print
EPS Growth YoY (baseline: -5.7%)
For learning and research only — not investment advice. AlphaDog doesn’t hold stocks and isn’t your financial advisor.
You just read a full FITB dossier — scored verdict, valuation, and both sides, with sources. Sign in to run that on a name you hold, on current filings. A free account includes 10 credits a week, 1 per fresh run.